OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,320,916 | +17.1% | 864,822 | 0.0% | 1.32% | +52.8% |
Q2 2023 | $2,836,616 | +27.1% | 864,822 | 0.0% | 0.86% | +45.4% |
Q1 2023 | $2,231,241 | +38.7% | 864,822 | 0.0% | 0.59% | +38.3% |
Q4 2022 | $1,608,569 | +1.1% | 864,822 | 0.0% | 0.43% | 0.0% |
Q3 2022 | $1,591,000 | -14.4% | 864,822 | 0.0% | 0.43% | -39.7% |
Q2 2022 | $1,859,000 | -30.6% | 864,822 | +1.4% | 0.71% | -37.7% |
Q1 2022 | $2,678,000 | +108.6% | 852,888 | +113.2% | 1.14% | +167.4% |
Q4 2021 | $1,284,000 | +63.6% | 400,000 | +71.3% | 0.43% | +86.0% |
Q3 2021 | $785,000 | -8.1% | 233,510 | +6.9% | 0.23% | +15.1% |
Q2 2021 | $854,000 | -14.2% | 218,510 | -11.7% | 0.20% | 0.0% |
Q1 2021 | $995,000 | -47.9% | 247,510 | -70.1% | 0.20% | -63.0% |
Q4 2020 | $1,911,000 | -46.1% | 827,260 | +33.8% | 0.54% | -57.4% |
Q3 2020 | $3,548,000 | -11.5% | 618,092 | +13.6% | 1.26% | -19.4% |
Q2 2020 | $4,011,000 | +62.5% | 544,281 | -34.3% | 1.56% | -73.1% |
Q1 2020 | $2,469,000 | -29.5% | 828,413 | -1.8% | 5.82% | +120.2% |
Q4 2019 | $3,502,000 | +48.6% | 843,931 | +16.0% | 2.64% | +15.2% |
Q3 2019 | $2,356,000 | – | 727,260 | – | 2.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
XTX Topco Ltd | 50,569 | $198,000 | 0.07% |